Search Results - "Waubant, EL"

Assessing Efficacy in Clinical Trials of Treatments for Multiple Sclerosis: Issues and Controversy by Waubant, Emmanuelle L., Goodkin, Donald E.

Get full text

Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon Beta-1a (Avonex) Treatment in Multiple Sclerosis by Herndon, RM, Jacobs, LD, Coats, ME, Goodkin, DE, Mass, MK, Richert, JR, Rudick, RA, Waubant, EL, Weinstock-Guttman, B, Scaramucci, JO, Burnett, BK, Jones, WE, Simonian, NA

“…Abstract In a phase III, double-blind, placebo-controlled, 2-year clinical trial, interferon beta-1a (IFN-β-1a, Avonex) treatment significantly delayed…”
Get full text